The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06378580 · COMPLETED
Trial details
- NCT number
- NCT06378580
- Sponsor
- Luo Cong
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.